Patient Navigation to Improve Patient-Centered Cancer Care

NCT ID: NCT03226405

Last Updated: 2020-04-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-11-01

Study Completion Date

2023-10-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The MGH Cancer Center's patient navigation (PN) program, utilizes specially trained community-based personnel to improve cancer care in underserved communities by increasing cancer screening and removing barriers to timely care. This program incorporate rigorous evaluation to demonstrate the impact of innovation in healthcare delivery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This program allow cancer patients from MGH Community Health Centers (CHC) and surrounding communities who experience barriers to accessing care, including poverty, and limited English proficiency, and provide them navigation to receive timely, guideline-concordant treatment at MGH Cancer Center. By offering these vulnerable individuals a patient-centered approach to treatment, The investigators aim to promote patient engagement and increase access throughout the continuum of cancer care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient Navigation Program

* The study team will identify, track, and provide navigation for all adult patients referred to Cancer Center from the CHC and community partners for cancer treatment.
* The Patient Navigation Program include

* Education,
* Appointment reminders,
* Help with insurance,
* Transportation,
* Navigating the Cancer Center,
* Assisting in finding appropriate child care,
* Interpreting,
* Connecting the patient to psychosocial and/or palliative care teams,
* Physically escorting the patient to appointments

Group Type EXPERIMENTAL

Patient Navigation Program

Intervention Type OTHER

PN program improve access, timeliness and adherence with cancer treatment

Standard of Care

* The patients will receive enhanced usual care,
* This consist of personal phone call reminders about upcoming appointments at the MGH Cancer Center

Group Type ACTIVE_COMPARATOR

Usual Care

Intervention Type OTHER

the standard of care provided by the institution

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patient Navigation Program

PN program improve access, timeliness and adherence with cancer treatment

Intervention Type OTHER

Usual Care

the standard of care provided by the institution

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients (age 18 and older)
* Newly diagnosed with cancer referred from Massachusetts General Hospital (MGH) community health centers in

* Revere
* Chelsea
* Charlestown
* surrounding communities referred to receive cancer treatment at the MGH Cancer Center

Exclusion Criteria

-Patients that primary care providers exclude
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Massachusetts General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sanja Percac-Lima, MD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sanja Percac-Lima, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Massachusetts General Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Emma Whited

Role: CONTACT

617-724-1968

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Emma Whited

Role: primary

617-724-1968

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17-183

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Patient Navigation 2.0
NCT04234646 ACTIVE_NOT_RECRUITING NA
Trial of Patient Navigation-Activation
NCT00496678 COMPLETED PHASE4
Supportive Oncology Care at Home Post-Discharge
NCT04637035 ACTIVE_NOT_RECRUITING NA